HYPOSENS H2020 Project
Our breakthrough research will focus on the development, pre-clinical and clinical validation, and industrial demonstration of a unique all optical cancer prognostic system that will determine presence of cancer cells in the breast lymph nodes and characterize them, which correlates with presence of metastasis and bad prognosis.
The HypoSens imaging system is strategically designed to offer a minimally invasive alternative to the SLNB process.